Carl Barrett

Company: AstraZeneca

Job title: Vice President, Translational Medicine & Oncology

Seminars:

Panel Discussion & Q&A: The Role of Liquid Biopsy in Enabling Development of Biomarker-driven Targeted Therapies 6:35 pm

Evolving landscape of biomarker testing across tumour types Discovering actionable mechanisms of resistance in liquid biopsy Leveraging continued advances in liquid biopsy’s accessibility and accuracy to advance novel biomarker discoveryRead more

day: Agilent Engager

How are Regulatory Guidelines Evolving to Support MRD as a Diagnostic Tool, Implementable in the Clinic? 10:00 am

• The FNIH supports public health and the mission of the NIH through public private research partnerships, and Biomarkers Consortium projects bridge the gap between basic research and practical needs for advancing drug development and regulatory science • The FNIH ctDNA QCM project will provide quality control materials that will help real-world users to develop…Read more